Navigation Links
Director of Commerce, Rogers Weed, Presided Over Ribbon Cutting Ceremony Celebrating Opening of Expanded Manufacturing Facility at CMC Biologics
Date:9/22/2011

SEATTLE and COPENHAGEN, Denmark, Sept. 22, 2011 /PRNewswire/ -- CMC Biologics officially marked the opening of its state-of-the-art biopharmaceutical manufacturing facility, known as PF2, with a ribbon cutting ceremony on Wednesday, September 21, at its Bothell, Washington campus. The expansion of PF2 duplicates capacity and supports commercial manufacturing. Local political and business leaders attended the event.

(Photo: http://photos.prnewswire.com/prnh/20110922/SF73700)

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Director of Commerce of Washington State, Rogers Weed, who presided over the dedication of the facility said, "I'm delighted to see Washington State's life sciences sector grow and expand. This region benefits in many ways from companies like CMC Biologics, which manufactures clinical and commercial materials for companies throughout the world. This is an industry that will provide the people of Washington State with jobs and prosperity into the next century."

According to David Kauffmann, Chairman of the Board of CMC Biologics and Managing Director of European Equity Partners, "Our vision has always been to be a global market leader in contract biopharmaceutical process development and manufacturing services. This facility expansion represents one more step toward making that vision a reality."

"We are proud of the positive impact of this project on the local economy. CMC Biologics used mainly local contractors for the expansion and once the facility is operating at full capacity, we anticipate adding about 35 new employees to staff it," noted Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics. "I'd like to thank our contractors as well as all of the employees at CMC Biologics who were instrumental in bringing this project in on time and on budget."

The expansion project was led by Yonkers Industries, with support from Sellen, BMWC Constructors, Holaday-Parks, and Precision Electric Group, as well as other subcontractors.

About CMC Biologics

CMC Biologics (www.cmcbio.com) is a dedicated contract biopharmaceutical manufacturing and development organization with facilities in Copenhagen, Denmark and Seattle, Washington, USA. CMC Biologics specializes in custom services for scale up and cGMP manufacture of protein-based therapeutics for preclinical, clinical trials, and in-market production. The Company's fully integrated services includes cell line development using its proprietary CHEF1® system, process and formulation development, and comprehensive analytical testing. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers stirred tank and perfusion production processes.


'/>"/>
SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
2. Preetha Reddy, Managing Director, Apollo Hospitals Invited to United Nations Summit on NCDs
3. Rod Wolford Joins LABSCO Board of Directors
4. Gentris Corporation Announces Changes to Board of Directors
5. PTCB Board of Governors Announces Executive Director/CEO Murer Corrigan to Leave Organization
6. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
7. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
8. Hospira Expands Board of Directors
9. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
10. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
11. Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... INDIANAPOLIS , Feb. 12, 2016  Eli Lilly and ... High Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent ... in the UK, France , ... instructions to dilute the product only with dextrose solution.  ... of 2015, the UK Court of Appeal held that Lilly,s ...
(Date:2/12/2016)... BUFORD, Ga. , Feb. 12 2016  OMS ... office-based dental and medical practitioners, announced today the recent ... website offers visitors a variety of features that enhance ... purchase oral surgery supplies. --> ... Supply is a fairly new company that started in ...
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
Breaking Medicine Technology:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... In the ... forward. They’ll groom themselves to perfection, go out of their way to be romantic, ... – just take a look at any online dating profile. , A recent ...
(Date:2/12/2016)... ... , ... The law firm of Morrow, Morrow, Ryan & Bassett is offering ... scholarships is to encourage applicants to pursue a degree in their field of study ... , “We have available jobs in St. Landry and Evangeline Parishes that can ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... announced that nominations have closed for the ISE Southeast Awards 2016. Finalists and ... announced at the ISE® Southeast Executive Forum and Awards Gala on March 15, ...
(Date:2/12/2016)... ... 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor ... Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday ... This will be the first Fisher House in Nevada, and will provide free lodging ...
Breaking Medicine News(10 mins):